Dr. Machado is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1801 Senate Blvd
Ste 2000
Indianapolis, IN 46202Phone+1 317-962-9700Fax+1 317-962-9657
Education & Training
- Cleveland Clinic FoundationFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1996 - 2000
- Federal University of Rio Grande do Sul School of MedicineClass of 1993
Certifications & Licensure
- IN State Medical License 2017 - 2025
- IL State Medical License 2008 - 2020
- MD State Medical License 2003 - 2009
- OH State Medical License 2000 - 2004
- FL State Medical License 1999 - 2002
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Cardiovascular Complications of Sickle Cell Disease Start of enrollment: 2009 Mar 01
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 3083 citationsUpdated clinical classification of pulmonary hypertension.Gérald Simonneau, Michael A. Gatzoulis, Ian Adatia, David S. Celermajer, Christopher P. Denton
Journal of the American College of Cardiology. 2009-06-30 - 2819 citationsUpdated clinical classification of pulmonary hypertension.Gérald Simonneau, Michael A. Gatzoulis, Ian Adatia, David S. Celermajer, Christopher P. Denton
Journal of the American College of Cardiology. 2009-06-30 - 158 citationsAn Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell DiseaseElizabeth S. Klings, Roberto F. Machado, Robyn J. Barst, Claudia R. Morris, Kamal K. Mubarak
American Journal of Respiratory and Critical Care Medicine. 2014-03-15
Press Mentions
- ‘It Took Her so Fast’: 4-Year-Old Texas Preschooler Dies of COVID Within Hours of First SymptomsSeptember 10th, 2021
- Immunocompromised People Should Get a Third COVID-19 Vaccine Dose, CDC Committee SaysAugust 13th, 2021
- Along with Health and Safety Experts, We Would like to Remind You That Lysol Is PoisonApril 24th, 2020
- Join now to see all
Grant Support
- Vascular-targeted genomic and genetic strategies for acute chest syndrome (ACS)NHLBI2013–Present
- Carbon Monoxide Therapy For Severe Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2010–2011
- Use Of Bosentan In Patients With Symptomatic PH Associated With SCDNational Heart, Lung, And Blood Institute2008
- Natural History Of Sickle Cell Disease And Other Hemolytic DisordersClinical Center2007
- Use Of Bosentan In Patients With Symptomatic PH AssociatNational Heart, Lung, And Blood Institute2006
- Evaluation Of Endothelial Function In HIV Associated PAHClinical Center2006
- Cardiopulmonary Function Assessment And NO Based TherapiClinical Center2006
- Natural History Of Sickle Cell Disease And Other HemolytClinical Center2004–2006
- Natural History Of Sickle Cell Disease And Other HemolytClinical Center2005
- Effects Of Carbon Monoxide On Human Lung InflammationClinical Center2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: